Cellular entry of the SARS coronavirus

Trends in Microbiology

Volumn 12, Issue 10, 2004, Pages 466-472

  Hofmann, Heike ^a   Pöhlmann, Stefan ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; RECEPTOR PROTEIN; VIRUS RECEPTOR; VIRUS VACCINE; VITRONECTIN;

DENDRITIC CELL; ENZYME INHIBITION; MEMBRANE FUSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PH; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SARS CORONAVIRUS; TARGET CELL; VIRUS REPLICATION;

ANIMALS; DENDRITIC CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, VIRUS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ANIMALIA; CORONAVIRUS; RNA VIRUSES; SARS CORONAVIRUS;

EID: 4644323974     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2004.08.008     Document Type: Review

References (61)

1. K. Stadler SARS-beginning to understand a new virus Nat. Rev. Microbiol. 1 2003 209 218
2. C. Drosten Identification of a novel coronavirus in patients with severe acute respiratory syndrome N. Engl. J. Med. 348 2003 1967 1976
3. T.G. Ksiazek A novel coronavirus associated with severe acute respiratory syndrome N. Engl. J. Med. 348 2003 1953 1966
4. J.S. Peiris Coronavirus as a possible cause of severe acute respiratory syndrome Lancet 361 2003 1319 1325
5. R.A. Fouchier Aetiology: Koch's postulates fulfilled for SARS virus Nature 423 2003 240
6. T. Kuiken Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome Lancet 362 2003 263 270
7. M.A. Marra The Genome sequence of the SARS-associated coronavirus Science 300 2003 1399 1404
8. P.A. Rota Characterization of a novel coronavirus associated with severe acute respiratory syndrome Science 300 2003 1394 1399
9. Y. Guan Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China Science 302 2003 276 278
10. M. Eickmann Phylogeny of the SARS coronavirus Science 302 2003 1504 1505
11. E.J. Snijder Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage J. Mol. Biol. 331 2003 991 1004
12. Y. van Kooyk, and T.B. Geijtenbeek DC-SIGN: escape mechanism for pathogens Nat. Rev. Immunol. 3 2003 697 709
13. Marzi, A. et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of the severe acute respiratory syndrome coronavirus. J. Virol. (in press)
14. Z.Y. Yang pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN J. Virol. 78 2004 5642 5650
15. L. Kuo Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier J. Virol. 74 2000 1393 1406
16. A. Bonavia Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E J. Virol. 77 2003 2530 2538
17. T.M. Gallagher, and M.J. Buchmeier Coronavirus spike proteins in viral entry and pathogenesis Virology 279 2001 371 374
18. F. Taguchi The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding J. Virol. 69 1995 7260 7263
19. B. Delmas Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site J. Virol. 68 1994 5216 5224
20. R. Levis Multiple receptor-dependent steps determine the species specificity of HCV-229E infection Adv. Exp. Med. Biol. 380 1995 337 343
21. W. Li Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 2003 450 454
22. P. Wang Expression cloning of functional receptor used by SARS coronavirus Biochem. Biophys. Res. Commun. 315 2004 439 444
23. G.J. Babcock Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor J. Virol. 78 2004 4552 4560
24. S.K. Wong A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 J. Biol. Chem. 279 2004 3197 3201
25. X. Xiao The SARS-CoV S glycoprotein: expression and functional characterization Biochem. Biophys. Res. Commun. 312 2003 1159 1164
26. P. Towler ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis J. Biol. Chem. 279 2004 17996 18007
27. P. Prabakaran A model of the ACE2 structure and function as a SARS-CoV receptor Biochem. Biophys. Res. Commun. 314 2004 235 241
28. H. Hofmann Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor Biochem. Biophys. Res. Commun. 319 2004 1216 1231
29. K. Subbarao Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice J. Virol. 78 2004 3572 3577
30. S.R. Tipnis A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase J. Biol. Chem. 275 2000 33238 33243
31. M.A. Crackower Angiotensin-converting enzyme 2 is an essential regulator of heart function Nature 417 2002 822 828
32. I. Hamming Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis J. Pathol. 203 2004 631 637
33. Y. Ding The clinical pathology of severe acute respiratory syndrome (SARS): a report from China J. Pathol. 200 2003 282 289
34. J.M. Nicholls Lung pathology of fatal severe acute respiratory syndrome Lancet 361 2003 1773 1778
35. K.F. To Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases J. Pathol. 202 2004 157 163
36. Y. Ding Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways J. Pathol. 203 2004 622 630
37. W.K. Leung Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection Gastroenterology 125 2003 1011 1017
38. T.W. Lew Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome J. Am. Med. Assoc. 290 2003 374 380
39. J.S. Peiris Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Lancet 361 2003 1767 1772
40. H. Hofmann S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients J. Virol. 78 2004 6134 6142
41. G. Simmons Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry Proc. Natl. Acad. Sci. U. S. A. 101 2004 4240 4245
42. A.E. Smith, and A. Helenius How viruses enter animal cells Science 304 2004 237 242
43. D.S. Dimitrov Virus entry: molecular mechanisms and biomedical applications Nat. Rev. Microbiol. 2 2004 109 122
44. D.S. Dimitrov The secret life of ACE2 as a receptor for the SARS virus Cell 115 2003 652 653
45. Bosch, B.J. et al. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc. Natl. Acad. Sci. U. S. A. (in press)
46. C.A. de Haan Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion J. Virol. 78 2004 6048 6054
47. S.W. Liu Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors Lancet 363 2004 938 947
48. H. Bisht Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice Proc. Natl. Acad. Sci. U. S. A. 101 2004 6641 6646
49. D.M. Eckert, and P.S. Kim Mechanisms of viral membrane fusion and its inhibition Annu. Rev. Biochem. 70 2001 777 810
50. B.J. Bosch The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex J. Virol. 77 2003 8801 8811
51. B. Tripet Structural Characterization of the SARS-Coronavirus Spike S Fusion Protein Core J. Biol. Chem. 279 2004 20836 20849
52. J.M. Kilby, and J.J. Eron Novel therapies based on mechanisms of HIV-1 cell entry N. Engl. J. Med. 348 2003 2228 2238
53. J. Zhu Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors Biochem. Biophys. Res. Commun. 319 2004 283 288
54. Ingallinella, P. et al. Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus. Proc. Natl. Acad. Sci. U. S. A. (in press)
55. Z.Y. Yang A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice Nature 428 2004 561 564
56. Traggiai, E. et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. (in press)
57. W.T. Gao Effects of a SARS-associated coronavirus vaccine in monkeys Lancet 362 2003 1895 1896
58. J. Sui Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association Proc. Natl. Acad. Sci. U. S. A. 101 2004 2536 2541
59. M. Enserink Infectious diseases. One year after outbreak, SARS virus yields some secrets Science 304 2004 1097
60. S. Perlman Pathogenesis of coronavirus-induced infections. Review of pathological and immunological aspects Adv. Exp. Med. Biol. 440 1998 503 513
61. L. van der Hoek Identification of a new human coronavirus Nat. Med. 10 2004 368 373